|
|
Article: Third Wave Signs Agreement With Japan's National Cancer Center For Comprehensive Cancer Genotyping Program.
- Article from:
- PR Newswire
- Article date:
- April 2, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MADISON, Wis. -- Third Wave Technologies Inc. today announced that Japan's National Cancer Center (NCC) will use Third Wave Invader(R) products to genotype more than 100,000 different genetic variations in each of several hundred individuals in a large-scale study to discover the genetic foundations of cancer. This collaboration further expands Third Wave's leadership in the first-mover Japanese genetic analysis market.
The NCC study is believed to be the largest genomic discovery project ever aimed at understanding cancer. It is one of the cornerstones of Japan's comprehensive cancer program to decrease the incidence of the disease and improve the standard of ...